It is well established that some aspects of Aβ pathology may carry a transmission potential in certain circumstances, including administration of hGH as well as transplantation of hDM grafts regardless of iCJD occurrence, suggesting that the subsequent development of CAA may be treatment-induced through transmission routes similar to those of prion diseases. The gene discussed is GH1; the disease is prion disease.